Efficacy was found for the functional somatic syndromes group ( fibromyalgia and chronic fatigue syndrome ) , but not for anxiety or stress .
For other disorders , homeopathy produced mixed effects .
Meaningful safety data were lacking in the reports , but the superficial findings suggested good tolerability of homeopathy .
OBJECTIVE To systematic ally review  placebo-controlled r and omized trials of  homeopathy for psychiatric conditions .
A randomised, controlled, triple-blind trial of the efficacy of homeopathic treatment for chronic fatigue syndrome.
OBJECTIVE There is no management regime for chronic fatigue syndrome ( CFS ) that has been found to be universally beneficial and no treatment can be considered a " cure " . Patients with CFS may use complementary and alternative medicine ( CAM ) . Our aim was to evaluate homeopathic treatment in reducing subjective symptoms of CFS . METHOD Using a triple-blind design ( patient and homeopath blind to group assignment and data analyst blind to group until after initial analyses to reduce the possibility of bias due to data analyst ) , we r and omly assigned patients to homeopathic medicine or identical placebo .  One hundred and three patients meeting the Oxford criteria for CFS were recruited from two specialist hospital out patient departments . Patients had monthly consultations with a professional homeopath for 6 months . Main outcome measures were scores on the subscales of the Multidimensional Fatigue Inventory ( MFI ) and proportions of each group attaining clinical ly significant improvements on each subscale . Secondary outcome measures were the Fatigue Impact Scale ( FIS ) and the Functional Limitations Profile ( FLP ) .  Ninety-two patients completed treatment in the trial ( 47 homeopathic treatment , 45 placebo ) . Eighty-six patients returned fully or partially completed posttreatment outcome measures ( 41 homeopathic treatment group who completed treatment , 2 homeopathic treatment group who did not complete treatment , 38 placebo group who completed treatment , and 5 placebo group who did not complete treatment ) . RESULTS Seventeen of 103 patients withdrew from treatment or were lost to follow-up . Patients in the homeopathic medicine group showed significantly more improvement on the MFI general fatigue subscale ( one of the primary outcome measures ) and the FLP physical subscale but not on other subscales . Although group differences were not statistically significant on four out of the five MFI subscales ( the primary outcome measures ) , more people in the homeopathic medicine group showed clinical ly significant improvement . More people in the homeopathic medicine group showed clinical improvement on all primary outcomes ( relative risk=2.75 , P=.09 ) . CONCLUSIONS There is weak but equivocal evidence that the effects of homeopathic medicine are superior to placebo . Results also suggest that there may be nonspecific benefits from the homeopathic consultation . Further studies are needed to determine whether these differences hold in larger sample
Efficacy was found for the functional somatic syndromes group ( fibromyalgia and chronic fatigue syndrome ) , but not for anxiety or stress .
For other disorders , homeopathy produced mixed effects .
Meaningful safety data were lacking in the reports , but the superficial findings suggested good tolerability of homeopathy .
OBJECTIVE To systematic ally review  placebo-controlled r and omized trials of  homeopathy for psychiatric conditions .